BACKGROUND: The calibrated automated thrombogram (CAT) assay measures thrombin generation in plasma. OBJECTIVE: Use the CAT assay to detect endogenous tissue factor (TF) in recalcified platelet-rich plasma (PRP) and platelet-free plasma (PFP). METHODS: Blood from healthy volunteers was collected into citrate and incubated at 37 degrees C with or without lipopolysaccharide (LPS) for 5 hours. PRP and PFP were prepared and clotting was initiated by recalcification. Thrombin generation was measured using the CAT assay. RESULTS: The lag time (LT) was significantly shortened in PRP prepared from LPS-treated blood compared with untreated blood (10+/-3 min versus 20+/-6 min), and this change was reversed by the addition of inactivated human factor VIIa. LPS stimulation did not change the peak thrombin. Similar results were observed in PFP (21+/-4 min versus 35+/-5 min). LPS stimulation also significantly reduced the LT of PRP and PFP derived from blood containing citrate and a factor XIIa inhibitor. Finally, a low concentration of exogenous TF shortened the LT of PFP prepared from unstimulated, citrated blood without affecting the peak thrombin. CONCLUSION: Changes in LT in the CAT assay can be used to monitor levels of endogenous TF in citrated plasma. Copyright 2009 Elsevier Ltd. All rights reserved.
BACKGROUND: The calibrated automated thrombogram (CAT) assay measures thrombin generation in plasma. OBJECTIVE: Use the CAT assay to detect endogenous tissue factor (TF) in recalcified platelet-rich plasma (PRP) and platelet-free plasma (PFP). METHODS: Blood from healthy volunteers was collected into citrate and incubated at 37 degrees C with or without lipopolysaccharide (LPS) for 5 hours. PRP and PFP were prepared and clotting was initiated by recalcification. Thrombin generation was measured using the CAT assay. RESULTS: The lag time (LT) was significantly shortened in PRP prepared from LPS-treated blood compared with untreated blood (10+/-3 min versus 20+/-6 min), and this change was reversed by the addition of inactivated human factor VIIa. LPS stimulation did not change the peak thrombin. Similar results were observed in PFP (21+/-4 min versus 35+/-5 min). LPS stimulation also significantly reduced the LT of PRP and PFP derived from blood containing citrate and a factor XIIa inhibitor. Finally, a low concentration of exogenous TF shortened the LT of PFP prepared from unstimulated, citrated blood without affecting the peak thrombin. CONCLUSION: Changes in LT in the CAT assay can be used to monitor levels of endogenous TF in citrated plasma. Copyright 2009 Elsevier Ltd. All rights reserved.
Authors: Florian Langer; Felix Kyoung-Hwan Chun; Ali Amirkhosravi; Martin Friedrich; Sven Leuenroth; Barbara Eifrig; Carsten Bokemeyer; John L Francis Journal: Thromb Haemost Date: 2007-03 Impact factor: 5.249
Authors: Yesim Dargaud; M Christine Trzeciak; Jean Claude Bordet; Jacques Ninet; Claude Negrier Journal: Thromb Haemost Date: 2006-11 Impact factor: 5.249
Authors: M E T Tesselaar; F P H T M Romijn; I K Van Der Linden; F A Prins; R M Bertina; S Osanto Journal: J Thromb Haemost Date: 2006-12-13 Impact factor: 5.824
Authors: A W J H Dielis; E Castoldi; H M H Spronk; R van Oerle; K Hamulyák; H Ten Cate; J Rosing Journal: J Thromb Haemost Date: 2007-11-06 Impact factor: 5.824
Authors: Joost J van Veen; Alex Gatt; Peter C Cooper; Steven Kitchen; Annette E Bowyer; Mike Makris Journal: Blood Coagul Fibrinolysis Date: 2008-04 Impact factor: 1.276
Authors: Martin Koestenberger; Gerhard Cvirn; Bert Nagel; Andrea Rosenkranz; Bettina Leschnik; Andreas Gamillscheg; Albrecht Beitzke; Wolfgang Muntean Journal: Thromb Res Date: 2007-10-03 Impact factor: 3.944
Authors: Hansjörg Schwertz; Neal D Tolley; Jason M Foulks; Melvin M Denis; Ben W Risenmay; Michael Buerke; Rachel E Tilley; Matthew T Rondina; Estelle M Harris; Larry W Kraiss; Nigel Mackman; Guy A Zimmerman; Andrew S Weyrich Journal: J Exp Med Date: 2006-10-23 Impact factor: 14.307
Authors: J E Geddings; Y Hisada; Y Boulaftali; T M Getz; M Whelihan; R Fuentes; R Dee; B C Cooley; N S Key; A S Wolberg; W Bergmeier; N Mackman Journal: J Thromb Haemost Date: 2015-12-11 Impact factor: 5.824
Authors: Niklas Boknäs; Lars Faxälv; Jakob O Ström; Pentti Tengvall; Elvar Theodorsson; Sofia Ramström; Tomas L Lindahl Journal: Blood Date: 2014-09-04 Impact factor: 22.113
Authors: Kellie R Machlus; Emily A Colby; Jogin R Wu; Gary G Koch; Nigel S Key; Alisa S Wolberg Journal: Thromb Haemost Date: 2009-11 Impact factor: 5.249
Authors: Pierre-Emmanuel Rautou; Kohei Tatsumi; Silvio Antoniak; A Phillip Owens; Erica Sparkenbaugh; Lori A Holle; Alisa S Wolberg; Anna K Kopec; Rafal Pawlinski; James P Luyendyk; Nigel Mackman Journal: J Hepatol Date: 2015-08-29 Impact factor: 25.083